Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Retinal toxicity of systemic medications.

Labriola LT, Jeng D, Fawzi AA.

Int Ophthalmol Clin. 2012 Winter;52(1):149-66. doi: 10.1097/IIO.0b013e31823bbad5. Review. No abstract available.

PMID:
22124243
2.

Drugs and the retina.

Constable S, Pirmohamed M.

Expert Opin Drug Saf. 2004 May;3(3):249-59. Review.

PMID:
15155152
3.

Medications and retinal toxicity.

Schwartz SG, Mieler WF.

Ophthalmol Clin North Am. 2002 Dec;15(4):517-28. Review.

PMID:
12515084
4.

[Retinal drug targets].

Behar-Cohen F.

Ann Pharm Fr. 2011 Mar;69(2):124-30. doi: 10.1016/j.pharma.2011.01.003. Review. French.

PMID:
21440105
5.

Retinal and ocular toxicity in ocular application of drugs and chemicals--part II: retinal toxicity of current and new drugs.

Penha FM, Rodrigues EB, Maia M, Furlani BA, Regatieri C, Melo GB, Magalhães O Jr, Manzano R, Farah ME.

Ophthalmic Res. 2010;44(4):205-24. doi: 10.1159/000316695. Review.

6.

[Ocular side effects of drugs].

Müller-Breitenkamp U, Hockwin O.

Laryngorhinootologie. 1992 Apr;71(4):226-8. Review. German.

PMID:
1575856
7.

Retinopathy induced by drugs and herbal medicines.

Nencini C, Barberi L, Runci FM, Micheli L.

Eur Rev Med Pharmacol Sci. 2008 Sep-Oct;12(5):293-8. Review.

PMID:
19024212
8.

Screening for hydroxychloroquine toxicity.

Pulido JS, Barkmeier AJ, Leavitt JA, Lewis RA.

Ophthalmology. 2012 Jan;119(1):207; author reply 207-8. doi: 10.1016/j.ophtha.2011.09.041. No abstract available.

PMID:
22214958
9.

Retinal toxicity of high dose intravitreal ganciclovir.

Saran BR, Maguire AM.

Retina. 1994;14(3):248-52.

PMID:
7973120
10.

Amsler grids for chloroquine toxicity.

Flach AJ.

Ophthalmology. 2011 Oct;118(10):2099; author reply 2099-100. doi: 10.1016/j.ophtha.2011.07.018. No abstract available.

PMID:
21968178
11.

Retinal toxicity of chlorpromazine in the rat.

Legros J, Rosner I, Berger C.

Toxicol Appl Pharmacol. 1973 Nov;26(3):459-65. No abstract available.

PMID:
4767581
12.

Acute retinal toxicity from the novel anti-tumor agent, Irofulven.

Melendez RF, Harrison JM, Rowinsky EK, Hammond LA, Fitzsimmons TD.

Doc Ophthalmol. 2004 May;108(3):249-51. No abstract available.

PMID:
15573949
13.

Crystalline retinopathies.

Drenser K, Sarraf D, Jain A, Small KW.

Surv Ophthalmol. 2006 Nov-Dec;51(6):535-49. Review.

PMID:
17134644
14.

Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.

Kalina RE, Wells CG.

Am J Ophthalmol. 1995 Jan;119(1):112-3. No abstract available.

PMID:
7825684
15.

Indocyanine green toxicity.

Allen RC, Oetting TA.

Ophthalmology. 2007 Jan;114(1):197; author reply 197. No abstract available.

PMID:
17198861
16.

Bilateral vitelliform maculopathy and deferoxamine toxicity.

Gonzales CR, Lin AP, Engstrom RE, Kreiger AE.

Retina. 2004 Jun;24(3):464-7. No abstract available.

PMID:
15187676
17.

Screening for vigabatrin (Sabril ®) retinal toxicity in children.

Brodie SE.

Ophthalmic Genet. 2011 Nov;32(4):193-5. doi: 10.3109/13816810.2011.574185. No abstract available.

PMID:
21895515
18.

Poppers-associated retinal toxicity.

Vignal-Clermont C, Audo I, Sahel JA, Paques M.

N Engl J Med. 2010 Oct 14;363(16):1583-5. doi: 10.1056/NEJMc1005118. No abstract available.

19.

Screening for hydroxychloroquine retinal toxicity: is it necessary?

Morsman CD, Livesey SJ, Richards IM, Jessop JD, Mills PV.

Eye (Lond). 1990;4 ( Pt 4):572-6.

PMID:
2226986
20.

Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.

Santana M, Wiedemann P, Kirmani M, Minckler DS, Patterson R, Sorgente N, Ryan SJ.

Graefes Arch Clin Exp Ophthalmol. 1984;221(5):210-3.

PMID:
6489768

Supplemental Content

Support Center